oral glutathione skin whitening randomized controlled trial as a agent: Facts, myths, evidence and controversies Glutathione as a skin‐lightening agent

doi: 10.1016/j.phytochem.2022.113459 29 SilbersteinTHar-VardiIHarlevAFrigerMHamouBBaracTet al

Tesamorelin Mechanism Type: GHRH analog Action: Mimics endogenous GHRH to directly stimulate the pituitary Primary Benefit: Increases GH to promote lipolysis and VAT reduction This direct pathway makes Tesamorelin highly targeted for fat loss and metabolic correction

IGF-1 DES binds IGFBP-3 poorly, similar to LR3, but it also has roughly ten-fold higher potency at IGF-1R because the N-terminal tripeptide normally dampens receptor-binding affinity

Cancer promotion concerns arise from IGF-1's well-established role in cellular proliferation, survival, and growth

Where this lands If your goal is visceral fat reduction specifically, tesamorelin is the only GHRH analog with direct clinical evidence for that endpoint, but that evidence comes from HIV lipodystrophy patients, not from the general population